Approval for the synergy everolimus-eluting platinum chromium coronary stent system. this device is indicated for improving luminal diameter in patients with symptomatic heart disease, stableangina, unstable angina, non-st elevation mi or documented silent ischemia due to atherosclerotic lesions in native coronary arteries >=2.25 mm to <=4.0 mm in diameter in lesions <=34 mm in length.